InvestorsHub Logo
Followers 1
Posts 9
Boards Moderated 0
Alias Born 12/02/2016

Re: None

Monday, 01/09/2017 9:19:52 PM

Monday, January 09, 2017 9:19:52 PM

Post# of 8299
LEVO-CTS targeted LCOS; 35 published trials already confirmed greater than 50% reduction in mortality.
http://cdn.irdirect.net/IR/942/1803/TENX%20Overview%20--%20Nov%202016%20.pdf (pg 5)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News